Cargando…

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial

Higher doses of intravenous rifampicin may improve outcomes in tuberculous meningitis but are impractical in high-burden settings. We hypothesized that plasma rifampicin exposures would be similar between oral dosing of 35 mg/kg of body weight and intravenous dosing of 20 mg/kg, which has been propo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasserman, Sean, Davis, Angharad, Stek, Cari, Chirehwa, Maxwell, Botha, Stephani, Daroowala, Remy, Bremer, Marise, Maxebengula, Mpumi, Koekemoer, Sonya, Goliath, Rene, Jackson, Amanda, Crede, Thomas, Naude, Jonathan, Szymanski, Patryk, Vallie, Yakoob, Moosa, Muhammed S., Wiesner, Lubbe, Black, John, Meintjes, Graeme, Maartens, Gary, Wilkinson, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611291/ https://www.ncbi.nlm.nih.gov/pubmed/33972248 http://dx.doi.org/10.1128/AAC.00140-21

Ejemplares similares

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial
por: Davis, Angharad G, et al.
Publicado: (2022)

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
por: Davis, Angharad G., et al.
Publicado: (2021)

Cognitive Impairment in Tuberculous Meningitis
por: Davis, Angharad G, et al.
Publicado: (2022)

Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2022)

The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research
por: Walker, Naomi F., et al.
Publicado: (2018)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
por: Rockwood, Neesha, et al.
Publicado: (2016)

Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications
por: Court, R., et al.
Publicado: (2018)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020)

Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
por: Riou, Catherine, et al.
Publicado: (2021)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis
por: Abdelgawad, Noha, et al.
Publicado: (2022)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021)

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study
por: De Nicolò, Amedeo, et al.
Publicado: (2022)

Validation of a quantitative liquid chromatography tandem mass spectrometry assay for linezolid in cerebrospinal fluid and its application to patients with HIV-associated TB-meningitis
por: Mazanhanga, Marian, et al.
Publicado: (2023)

Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
por: du Bruyn, Elsa, et al.
Publicado: (2023)

Diagnostic Accuracy of the INSHI Consensus Case Definition for the Diagnosis of Paradoxical Tuberculosis-IRIS
por: Stek, Cari, et al.
Publicado: (2021)

Clofazimine pharmacokinetics in patients with TB: dosing implications
por: Abdelwahab, Mahmoud Tareq, et al.
Publicado: (2020)

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
por: Griesel, Rulan, et al.
Publicado: (2023)

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans
por: Johnston, Jenna, et al.
Publicado: (2019)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study
por: Keene, Claire M, et al.
Publicado: (2021)

Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment
por: van Beek, Stijn W, et al.
Publicado: (2022)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)
por: Stek, Cari, et al.
Publicado: (2016)

The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy
por: Stek, Cari, et al.
Publicado: (2018)

Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
por: Ngwalero, Precious, et al.
Publicado: (2021)

Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis
por: Court, R. G., et al.
Publicado: (2018)

Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
por: Riou, Catherine, et al.
Publicado: (2022)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Relationship Between LTA4H Promotor Polymorphism and Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Its Prevention With Prednisone
por: Stek, Cari, et al.
Publicado: (2023)

Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis
por: van der Plas, Helen, et al.
Publicado: (2013)

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
por: Decloedt, Eric H., et al.
Publicado: (2021)

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
por: Zhang, C, et al.
Publicado: (2010)

Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
por: Spies, Ruan, et al.
Publicado: (2022)

Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life
por: Wouters, Edwin, et al.
Publicado: (2022)

The Safety, Effectiveness and Concentrations of Adjusted Lopinavir/Ritonavir in HIV-Infected Adults on Rifampicin-Based Antitubercular Therapy
por: Decloedt, Eric H., et al.
Publicado: (2012)

The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function
por: Stek, Cari, et al.
Publicado: (2020)

Correction: Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country
por: Moosa, Mohammed Rafique, et al.
Publicado: (2016)

Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country
por: Moosa, Mohammed Rafique, et al.
Publicado: (2016)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
por: Zhao, Ying, et al.
Publicado: (2022)

Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa
por: van der Walt, Martie, et al.
Publicado: (2020)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vc4uffsv2pfpve3buv49evlaip